Abstract |
The use of Hypoxis hemerocallidea Fisch. and C.A. Mey. (Hypoxidaceae) extracts for ailments other than benign prostate hyperplasia (BPH) is now a reality. The whole extract, the phytosterols, as well as the major constituents it contains ( hypoxoside, and its active derivative rooperol) are now finding new applications in the area of anti-oxidants, anti-inflammatories, anti-diabetics, anti- convulsants, inhibitors of drug marker substances and new evidence is presented of activity against cancerous and premalignant cancer cells. In addition, the over-the-counter (OTC) trade has undergone enormous expansion.
|
Authors | S E Drewes, E Elliot, F Khan, J T B Dhlamini, M S S Gcumisa |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 119
Issue 3
Pg. 593-8
(Oct 28 2008)
ISSN: 0378-8741 [Print] Ireland |
PMID | 18602776
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Anticonvulsants
- Antineoplastic Agents, Phytogenic
- Antioxidants
- Hypoglycemic Agents
- Nonprescription Drugs
- Phytosterols
- Plant Extracts
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(pharmacology)
- Anticonvulsants
(pharmacology)
- Antineoplastic Agents, Phytogenic
(pharmacology)
- Antioxidants
(pharmacology)
- Humans
- Hypoglycemic Agents
(pharmacology)
- Hypoxis
(chemistry)
- Male
- Nonprescription Drugs
- Phytosterols
(chemistry, isolation & purification, pharmacology)
- Phytotherapy
- Plant Extracts
(pharmacology, therapeutic use)
- Prostatic Hyperplasia
(drug therapy)
|